Also known as آسٹیوپوروسس مینجمنٹ
Cardiologist
M.B.B.S., F.C.P.S., MRCP
Gastroenterologist
M.B.B.S., F.C.P.S. (Gastroenterology)
Pulmonologist
M.B.B.S., F.C.P.S. (Medicine), F.C.P.S. (Pulmanology)
Endocrinologist
MBBS, MRCP (Diabetes & Endocrinology), CCT (Endocrinology & Diabetes), CCT General Internal Medicine, FRCP
Endocrinologist
MBBS, MRCP (Diabetes & Endocrinology), CCT (Endocrinology & Diabetes), CCT General Internal Medicine, FRCP
Internal Medicine Specialist
MD(Neurology), F.C.P.S. (Medicine), MRCP (UK), FRCP LONDON
Internal Medicine Specialist
MD(Neurology), F.C.P.S. (Medicine), MRCP (UK), FRCP LONDON
Consultant Physician
MBBS, MSc Diabetes and Endocrinology
Diabetologist
M.B.B.S., Diploma in Diabetology
Gastroenterologist
MBBS, FCPS (Gastroenterology)
Gastroenterologist
MCPS-HPE (Health Professional Education), FCPS (Gastroenterology and Hepatology), MCPS (General/Internal Medicine), MBBS, FRCP (UK)
Gastroenterologist
MCPS-HPE (Health Professional Education), FCPS (Gastroenterology and Hepatology), MCPS (General/Internal Medicine), MBBS, FRCP (UK)
Internal Medicine Specialist
MBBS, MRCP (UK), MRCGP (UK), MRCPS (Glasgow), CCT (UK)
Internal Medicine Specialist
MBBS, MRCP (UK), MRCGP (UK), MRCPS (Glasgow), CCT (UK)
Bisphosphonates are used as first-line pharmacologictreatment for osteoporosis. In patients who cannot tolerate or whose symptoms do not improve with bisphosphonate therapy, teriparatide (Forteo) and denosumab (Prolia) are effective alternative medications to prevent osteoporotic fractures